Professor David Kerr warns against 'treating the marker' in CRC. Should rising ctDNA trigger chemo without radiologic proof?

Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most challenging malignancies to treat due to its highly ...

Intrahepatic cholangiocarcinoma (iCCA), the second most common primary liver cancer after hepatocellular carcinoma, remains one of the most ...

Research shows tumor debulking in advanced colorectal cancer does not enhance survival outcomes and may increase adverse ...

A routine blood report often brings relief. Numbers fall within range, the doctor nods, and life moves on. Yet, many people ...

Detailed price information for Bolt Biotherapeutics Inc (BOLT-Q) from The Globe and Mail including charting and trades.

USANewsGroup.com News Commentary-- The global cell therapy manufacturing market is hitting a pivotal inflection point. It's ...

Follicular lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment ...

Detection of a bowel cancer marker (CDH1) in wastewater may offer a new community-level early warning system for the disease, suggests a proof-of-concept study published in the Journal of Epidemiology ...